Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress

Kuang Ti Chen, Ching Hsiang Wu, Mang Hung Tsai, Ya Chieh Wu, Ming Jia Jou, Chih Chia Huang, I. Hua Wei

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sarcosine, an N-methyl-D-aspartate receptor enhancer, can improve depression-like behavior in rodent models and depression in humans. We found that a single dose of sarcosine exerted antidepressant-like effects with rapid concomitant increases in the mammalian target of rapamycin (mTOR) signaling pathway activation and enhancement of α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor (AMPAR) membrane insertion. Sarcosine may play a crucial role in developing novel therapy for depression. For a detailed understanding of sarcosine, this study examined the effects of long-term sarcosine treatment on the forced swim test (FST), mTOR signaling, and AMPAR membrane insertion in rats. The effects of long-term sarcosine treatment were examined in naive rats and rats exposed to chronic unpredictable stress (CUS). Long-term sarcosine treatment (560 mg/kg/d for 21 d) significantly ameliorated the increased immobility induced by CUS in the FST, reaffirming the potential role of sarcosine as an antidepressant for depressed patients. The same long-term treatment exhibited no such effect in naive rats despite increased mTOR activation and AMPAR membrane insertion in both groups. Our findings clearly show CUS-exposed rats are sensitive to long-term sarcosine treatment in FST and the response at the same dose is absent in naïve rats. Nevertheless, the distinct sensitivity to long-term sarcosine treatment in rats with or without CUS is not associated with the activated mTOR signaling pathway or increased AMPAR membrane insertion. Additionally, understanding the behavioral and molecular basis of distinct responses is vital important for developing personalized treatment programs to increase the probability of success when treating depression.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalBehavioural Brain Research
Volume316
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Sarcosine
Antidepressive Agents
Propionates
Sirolimus
Therapeutics
Membranes
N-Methyl-D-Aspartate Receptors
Rodentia

Keywords

  • AMPA
  • Depression
  • Long-term treatment
  • mTOR
  • Sarcosine

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress. / Chen, Kuang Ti; Wu, Ching Hsiang; Tsai, Mang Hung; Wu, Ya Chieh; Jou, Ming Jia; Huang, Chih Chia; Wei, I. Hua.

In: Behavioural Brain Research, Vol. 316, 01.01.2017, p. 1-10.

Research output: Contribution to journalArticle

Chen, Kuang Ti ; Wu, Ching Hsiang ; Tsai, Mang Hung ; Wu, Ya Chieh ; Jou, Ming Jia ; Huang, Chih Chia ; Wei, I. Hua. / Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress. In: Behavioural Brain Research. 2017 ; Vol. 316. pp. 1-10.
@article{82b3df0bfc2041d7b9c8f841a0f2432b,
title = "Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress",
abstract = "Sarcosine, an N-methyl-D-aspartate receptor enhancer, can improve depression-like behavior in rodent models and depression in humans. We found that a single dose of sarcosine exerted antidepressant-like effects with rapid concomitant increases in the mammalian target of rapamycin (mTOR) signaling pathway activation and enhancement of α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor (AMPAR) membrane insertion. Sarcosine may play a crucial role in developing novel therapy for depression. For a detailed understanding of sarcosine, this study examined the effects of long-term sarcosine treatment on the forced swim test (FST), mTOR signaling, and AMPAR membrane insertion in rats. The effects of long-term sarcosine treatment were examined in naive rats and rats exposed to chronic unpredictable stress (CUS). Long-term sarcosine treatment (560 mg/kg/d for 21 d) significantly ameliorated the increased immobility induced by CUS in the FST, reaffirming the potential role of sarcosine as an antidepressant for depressed patients. The same long-term treatment exhibited no such effect in naive rats despite increased mTOR activation and AMPAR membrane insertion in both groups. Our findings clearly show CUS-exposed rats are sensitive to long-term sarcosine treatment in FST and the response at the same dose is absent in na{\"i}ve rats. Nevertheless, the distinct sensitivity to long-term sarcosine treatment in rats with or without CUS is not associated with the activated mTOR signaling pathway or increased AMPAR membrane insertion. Additionally, understanding the behavioral and molecular basis of distinct responses is vital important for developing personalized treatment programs to increase the probability of success when treating depression.",
keywords = "AMPA, Depression, Long-term treatment, mTOR, Sarcosine",
author = "Chen, {Kuang Ti} and Wu, {Ching Hsiang} and Tsai, {Mang Hung} and Wu, {Ya Chieh} and Jou, {Ming Jia} and Huang, {Chih Chia} and Wei, {I. Hua}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.bbr.2016.06.004",
language = "English",
volume = "316",
pages = "1--10",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress

AU - Chen, Kuang Ti

AU - Wu, Ching Hsiang

AU - Tsai, Mang Hung

AU - Wu, Ya Chieh

AU - Jou, Ming Jia

AU - Huang, Chih Chia

AU - Wei, I. Hua

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Sarcosine, an N-methyl-D-aspartate receptor enhancer, can improve depression-like behavior in rodent models and depression in humans. We found that a single dose of sarcosine exerted antidepressant-like effects with rapid concomitant increases in the mammalian target of rapamycin (mTOR) signaling pathway activation and enhancement of α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor (AMPAR) membrane insertion. Sarcosine may play a crucial role in developing novel therapy for depression. For a detailed understanding of sarcosine, this study examined the effects of long-term sarcosine treatment on the forced swim test (FST), mTOR signaling, and AMPAR membrane insertion in rats. The effects of long-term sarcosine treatment were examined in naive rats and rats exposed to chronic unpredictable stress (CUS). Long-term sarcosine treatment (560 mg/kg/d for 21 d) significantly ameliorated the increased immobility induced by CUS in the FST, reaffirming the potential role of sarcosine as an antidepressant for depressed patients. The same long-term treatment exhibited no such effect in naive rats despite increased mTOR activation and AMPAR membrane insertion in both groups. Our findings clearly show CUS-exposed rats are sensitive to long-term sarcosine treatment in FST and the response at the same dose is absent in naïve rats. Nevertheless, the distinct sensitivity to long-term sarcosine treatment in rats with or without CUS is not associated with the activated mTOR signaling pathway or increased AMPAR membrane insertion. Additionally, understanding the behavioral and molecular basis of distinct responses is vital important for developing personalized treatment programs to increase the probability of success when treating depression.

AB - Sarcosine, an N-methyl-D-aspartate receptor enhancer, can improve depression-like behavior in rodent models and depression in humans. We found that a single dose of sarcosine exerted antidepressant-like effects with rapid concomitant increases in the mammalian target of rapamycin (mTOR) signaling pathway activation and enhancement of α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor (AMPAR) membrane insertion. Sarcosine may play a crucial role in developing novel therapy for depression. For a detailed understanding of sarcosine, this study examined the effects of long-term sarcosine treatment on the forced swim test (FST), mTOR signaling, and AMPAR membrane insertion in rats. The effects of long-term sarcosine treatment were examined in naive rats and rats exposed to chronic unpredictable stress (CUS). Long-term sarcosine treatment (560 mg/kg/d for 21 d) significantly ameliorated the increased immobility induced by CUS in the FST, reaffirming the potential role of sarcosine as an antidepressant for depressed patients. The same long-term treatment exhibited no such effect in naive rats despite increased mTOR activation and AMPAR membrane insertion in both groups. Our findings clearly show CUS-exposed rats are sensitive to long-term sarcosine treatment in FST and the response at the same dose is absent in naïve rats. Nevertheless, the distinct sensitivity to long-term sarcosine treatment in rats with or without CUS is not associated with the activated mTOR signaling pathway or increased AMPAR membrane insertion. Additionally, understanding the behavioral and molecular basis of distinct responses is vital important for developing personalized treatment programs to increase the probability of success when treating depression.

KW - AMPA

KW - Depression

KW - Long-term treatment

KW - mTOR

KW - Sarcosine

UR - http://www.scopus.com/inward/record.url?scp=84983740841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983740841&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2016.06.004

DO - 10.1016/j.bbr.2016.06.004

M3 - Article

VL - 316

SP - 1

EP - 10

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -